EX02 CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EX02 CAR-T Cells, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia [EARLY_Phase 1]